Stock IRRAS IRRAS AB
Add to a list
To use this feature you must be a member
Log inSign up

IRRAS AB Share Price

Equities

IRRAS

SE0008321202

Medical Equipment, Supplies & Distribution

Delayed Nasdaq Stockholm
Other stock markets
 05:29:43 03/11/2023 pm IST 		5-day change 1st Jan Change
0.1604 SEK -1.11% Intraday chart for IRRAS AB -.--% -.--%
2023 IRRAS AB(OM:IRRAS) dropped from OMX Nordic All-Share Index CI
2023 IRRAS AB(OM:IRRAS) dropped from OMX Nordic Small Cap Index CI

Financials

Sales 2023 * 165M 15.08M 1.26B Sales 2024 * 249M 22.72M 1.89B Capitalization 182M 16.61M 1.39B
Net income 2023 * -101M -9.23M -770M Net income 2024 * -29M -2.65M -221M EV / Sales 2023 * 2.38 x
Net Debt 2023 * 211M 19.26M 1.61B Net Debt 2024 * 258M 23.57M 1.97B EV / Sales 2024 * 1.77 x
P/E ratio 2023 *
-0.13 x
P/E ratio 2024 *
-0.43 x
Employees 47
Yield 2023 *
-
Yield 2024 *
-
Free-Float 3.55%
More Fundamentals * Assessed data

Chart IRRAS AB

Dynamic Chart

Latest news about IRRAS AB

IRRAS AB(OM:IRRAS) dropped from OMX Nordic All-Share Index CI
IRRAS AB(OM:IRRAS) dropped from OMX Nordic Small Cap Index CI
Irras Obtains Nasdaq Approval for Delisting in Stockholm MT
Sweden's Irras Files for Delisting as Privatization Nears Completion MT
Irras Obtains Extension for SEK20 Million Loan MT
Irras Shareholder Extends, Upsizes Loan MT
Legacy Capital Partners S.C.A. I, Spetses Investments Ltd, Bacara Holdings Limited, Lexington Holding Assets Ltd and Panormos Holding Limited completed the acquisition of a 26.6% stake in IRRAS AB (OM : IRRAS). CI
Swedish Medical Device Company Irras Warns of Possible High Risk of Insolvency MT
IR Holding Bidco Extends Acceptance Period for Irras Takeover MT
Transcript : IRRAS AB, Q2 2023 Earnings Call, Aug 04, 2023
Irras Extends Loan Agreement with Second-biggest Shareholder MT
IRRAS AB Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023 CI
Irras' Independent Bid Panel Backs IR Holding's SEK143 Million Takeover Offer MT
Irras Surges 19% on Takeover Offer From IR Holding Bidco MT
Legacy Capital Partners S.C.A. I, Spetses Investments Ltd, Bacara Holdings Limited, Lexington Holding Assets Ltd and Panormos Holding Limited agreed to acquire IRRAS AB (OM : IRRAS) for approximately SEK 140 million. CI
More news

Latest transcript on IRRAS AB

Logo IRRAS AB
IRRAS AB, Q2 2023 Earnings Call, Aug 04, 2023
More transcripts

Press releases IRRAS AB

IRRAS's application for delisting has been approved and the Board of Directors has resolved not to publish the interim report for the third quarter of 2023 AQ
NOTICE TO ATTEND THE EXTRAORDINARY GENERAL MEETING OF IRRAS AB AQ
IR Holding Bidco Inc. requests compulsory buy-out and IRRAS applies for delisting AQ
IRRAS publishes prospectus AQ
IRRAS has extended maturity date for its SEK 20 million short-term loan AQ
More press releases

Quotes and Performance

1 day-1.11%
6 months+0.25%
More quotes

Highs and lows

1 year
0.11
Extreme 0.1125
0.25
3 years
0.11
Extreme 0.1125
6.40
5 years
0.11
Extreme 0.1125
31.20
10 years
0.11
Extreme 0.1125
47.00
More quotes

Managers and Directors - IRRAS AB

Managers TitleAgeSince
Will Martin CEO
 Chief Executive Officer 49 01/18/01
Griffen Stapp DFI
 Director of Finance/CFO 38 -
Kleanthis Xanthopoulos BRD
 Director/Board Member 66 01/15/01
Members of the board TitleAgeSince
Marios Fotiadis CHM
 Chairman 51 01/12/01
Kleanthis Xanthopoulos BRD
 Director/Board Member 66 01/15/01
Inger Gunnel Anita Tollstadius BRD
 Director/Board Member 69 01/17/01
More insiders

Company Profile

Irras AB is a Sweden-based medical technology company. It offers devices for fluid control and management for a broad range of brain pathologies, central nervous system (CNS) therapeutic applications and procedures. The offer comprises instruments and catheters for the clinical, monitoring and surgical applications for brain pathology indications called IRRAflow. The IRRAflow CNS System combines an External Drainage System, an intracranial pressure monitoring (ICP) Monitor and an Occlusion Solution Mechanism into a single, integrated device. The primary market for IRRAflow is the United States. The Company’s shareholders comprise Vandel Medical Equipment (CY) Limited, Serendipity Ixora AB (publ) and F.EX Endotherapy Limited, among others.
Sector
Medical Equipment, Supplies & Distribution
More about the company

Income Statement Evolution

More financial data

Ratings for IRRAS AB

Trading Rating
Investor Rating
ESG Refinitiv
C
More Ratings

EPS Revisions

Estimates Revisions

Quarterly revenue - Rate of surprise

Company calendar

Sector Medical Devices & Implants

1st Jan change Capi.
IRRAS AB Stock IRRAS AB
-.--% 16.58M
STRYKER CORPORATION Stock Stryker Corporation
+12.07% 128B
SMITH & NEPHEW PLC Stock Smith & Nephew Plc
-9.04% 10.65B
IMEIK TECHNOLOGY DEVELOPMENT CO.,LTD. Stock Imeik Technology Development Co.,Ltd.
+0.91% 8.82B
INSPIRE MEDICAL SYSTEMS, INC. Stock Inspire Medical Systems, Inc.
+16.72% 7.19B
GLAUKOS CORPORATION Stock Glaukos Corporation
+25.15% 4.99B
AXONICS, INC. Stock Axonics, Inc.
+7.17% 3.4B
ENOVIS CORPORATION Stock Enovis Corporation
-1.36% 3.03B
BEIJING BALANCE MEDICAL TECHNOLOGY CO.,LTD. Stock Beijing Balance Medical Technology Co.,Ltd.
-8.73% 2.14B
SHANGHAI MICROPORT ENDOVASCULAR MEDTECH CO., LTD. Stock Shanghai MicroPort Endovascular MedTech Co., Ltd.
-10.15% 2B
Medical Devices & Implants
  1. Stock Market
  2. Equities
  3. IRRAS Stock